Barzolvolimab (CDX 0159) is a humanized monoclonal antibody targeting KIT that reduces skin mast cells and disease activity in chronic inducible urticaria.
Purity:
95.00%
CAS Number:
[2438203-51-9]
Target:
c-Kit
* VAT and and shipping costs not included. Errors and price changes excepted